• Update on Apealea, Potential Ovarian Cancer Therapy, Set for ASCO 2018 in June
  • Protein Levels Could Replace Genetic Tests for Detecting ARID1A Mutations
  • MAGENTA Study Seeks Women to Evaluate At-home Ovarian Cancer Genetic Test
  • Researchers Discover Mutations Behind Resistance to PARP Inhibitors Like Lynparza
  • Lynparza Tablets Approved in EU to Treat Advanced, Platinum-sensitive Ovarian Cancers
  • Siamab’s ST1 Therapy Candidate Promising Against Chemoresistant Ovarian Cancer, Study Shows
  • Phase 3 Trial of Mirvetuximab Soravtansine in Ovarian Cancer OK’d to Continue as Planned
  • Do Your Part to Support World Ovarian Cancer Day on May 8
  • Phase 2 Study May Be Added to Ongoing Trial of Combo Ovarian Cancer Immunotherapy
  • Zejula Shows Ability to Treat Range of Advanced Ovarian Cancers in Phase 2 Trial
  • IONTAS and IGEM Collaborate to Find Novel IgE Antibodies for Cancer Treatment
  • New Sensor Detects Ovarian Cancer in Noninvasive Manner in Mice, Study Shows